Search Results 781-790 of 17115 for treatment resistant depression
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter.
... resistant chronic lymphocytic leukemia. Patients ... Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since ...
Kids and screen time / transcranial magnetic stimulation therapy for depression / oral cancer reconstruction: Mayo Clinic Radio. As summer vacation rolls on ...
The purpose of Phase I of this study is to evaluate the safety and tolerability of CTX-712 in patients with relapsed/refractory (R/R) acute myeloid leukemia ( ...
... Resistant to Treatment Scottsdale/Phoenix, AZ; Rochester, MN. The purpose of ... treatment (refractory). Monoclonal antibodies, such as rituximab, may ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
administered for their underlying ovarian cancer. - Received prior therapy with PAC in the platinum-resistant recurrent setting - Evidence of clinically ...
Traumatic brain injury · Traumatic Brain Injury · Treatment-resistant depression · Tricyclic antidepressants · Vitamin B-12 and depression. Show more related ...
Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia. Print details. Share; Facebook · Twitter.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.